Press Releases

Featured Press Releases

BIO Applauds FTC Settlement Decision

Yesterday the Federal Trade Commission (FTC) announced the decision to settle its Amgen-Horizon merger challenge. The settlement will give the Commission the relief it needs to protect competition, while allowing rare disease patients to enjoy the…

Learn more

BIO Podcast 2023 Fall Season Launch

New Season of I am BIO Podcast Covers Birds, Bees, and Bugs Fall 2023 season explores biotech solutions for wildlife conservation, bee health, drug-resistant bugs, and more Washington – (Aug. 30, 2023) – Save the date―the Biotechnology Innovation…

Learn more

BIO Statement on CMS Announcement of First 10…

The Biden Administration today unveiled the first 10 prescription drugs that will be subject to price controls under the Inflation Reduction Act (IRA). Rachel King, BIO interim President and CEO, made the following statement: The Medicare price…

Learn more

Nominate Biotech Heroes for BIO's Impact Awards

May 8, 2023

Nominations are now open for two prestigious awards to honor today’s biotech heroes—innovators who are driving discoveries to strengthen agricultural, environmental and economic resiliency. Collectively known as the Biotechnology Innovation…

Organizations Focused on Fight Against Superbugs Celebrate Reintroduction of the PASTEUR Act

April 27, 2023

Groups urging need for revitalizing antimicrobial development call for passage of the bill this year Today, five prominent national organizations — the Biotechnology Innovation Organization, the Cystic Fibrosis Foundation, the Infectious…

Call for Sessions for BIO's Impact Ag & Environment Conference

April 27, 2023

BIO’s Impact Ag & Environment Conference, Sept. 19-20, 2023, in Raleigh, N.C., is an opportunity for companies and non-governmental organizations working across agriculture, bioprocessing, and climate adaptation/mitigation to connect and…

BIO to redouble efforts to ensure regulatory decision-making is "grounded in scientific and medical expertise"

April 21, 2023

The Supreme Court ruled today that mifepristone will remain accessible during the appeals process of the April 7 Texas ruling that would have declared the Food and Drug Administration (FDA) approval of the drug invalid. BIO interim…

BIO JOINS AMICUS BRIEF CHALLENGING COURT’S EFFORTS TO UNDERMINE FDA’S AUTHORITY TO BRING TREATMENTS AND CURES TO PATIENTS

April 11, 2023

BIO JOINS AMICUS BRIEF CHALLENGING COURT’S EFFORTS TO UNDERMINE FDA’S AUTHORITY TO BRING TREATMENTS AND CURES TO PATIENTS “We will continue to organize and mobilize America’s scientific community to challenge this unprecedented effort to undermine…

New ruling out of Texas sets "dangerous precedent for undermining the FDA"

April 8, 2023

A federal judge in Texas rules this week to suspend the FDA’s approval of mifepristone. BIO interim President and CEO, Rachel King, released the following statement: “The preliminary ruling by a federal judge in Texas is an assault on science…

Majority of American Voters Want Congress to Prioritize and Fund Public Health Preparedness, Poll Reveals

March 30, 2023

Healthcare Ready, Biotechnology Innovation Organization, and Wakefield Research release data Washington (March 30, 2023) -- The last several years have shown that preparing for a public health emergency is vital to protect the public, our…

Innovation & Jobs Act Needed to Spur Innovation and Strengthen America's Global Competitiveness

March 17, 2023

Biotechnology companies are hard at work on the cutting-edge innovations we need, but those breakthroughs are at risk from current tax policy. The Biotechnology Innovation Organization, which represents more than 1,000 biotech companies, thanks…

BIO Welcomes John Delacourt as Deputy General Counsel

March 15, 2023

Mr. Delacourt is a senior litigator and regulatory counselor with more than a decade of experience advising biotech companies WASHINGTON – (March 15, 2023) – The Biotechnology Innovation Organization (BIO) welcomes John Delacourt as Deputy General…

Silicon Valley Bank and Biotech

March 13, 2023

"The ecosystem that allows America to develop groundbreaking new medicines is extremely important to our nation and to patients who depend on biotechnology companies. The recent actions by the FDIC, the Federal Reserve, and Treasury to allow SVB…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.